NewsRx

Search our medical news database

Bioscience

Regado Biosciences Expands Medical Advisory Board

Published in Cardiovascular Business Week, August 4th, 2009

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, announced the expansion of its Medical Advisory Board (MAB). Three new members (Dr. John Eikelboom of Canada, Dr. Philippe Menasche of France and Dr. Lars Wallentin of Sweden) join the original members bringing the current size of the MAB to twelve. Regado's MAB comprises leaders in the fields of cardiology, thrombosis/coagulation and cardiovascular surgery who advise the Company on its clinical programs and provide strategic guidance to support the eventual commercialization of Regado's products, in particular, the Company's leading product...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook